Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcutis Biotherapeutics (ARQT) Change in Inventory (2022 - 2025)

Arcutis Biotherapeutics (ARQT) has 4 years of Change in Inventory data on record, last reported at $5000.0 in Q4 2025.

  • For Q4 2025, Change in Inventory fell 98.11% year-over-year to $5000.0; the TTM value through Dec 2025 reached $7.3 million, up 1732.25%, while the annual FY2025 figure was $7.3 million, 1732.25% up from the prior year.
  • Change in Inventory reached $5000.0 in Q4 2025 per ARQT's latest filing, down from $5.9 million in the prior quarter.
  • Across five years, Change in Inventory topped out at $5.9 million in Q3 2025 and bottomed at -$779000.0 in Q4 2023.
  • Average Change in Inventory over 4 years is $1.5 million, with a median of $835000.0 recorded in 2023.
  • The widest YoY moves for Change in Inventory: up 1626.55% in 2025, down 181.83% in 2025.
  • A 4-year view of Change in Inventory shows it stood at $3.2 million in 2022, then crashed by 124.29% to -$779000.0 in 2023, then skyrocketed by 134.02% to $265000.0 in 2024, then plummeted by 98.11% to $5000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Inventory were $5000.0 in Q4 2025, $5.9 million in Q3 2025, and -$518000.0 in Q2 2025.